Cargando…
Pembrolizumab-Induced Sarcoid-Like Reaction in a Patient With Lung Cancer
Cancer is not only the leading cause of mortality and morbidity but also poses a major economic burden. Until recently, onco-immunotherapy has dramatically changed the landscape of cancer treatment. For example, an inhibitor of programmed cell death (PD-1) plays a vital role by potentiating effectiv...
Autores principales: | Yousuf, Hira, Mekki, Rasheid, Khan, Khizer, Hussain, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779128/ https://www.ncbi.nlm.nih.gov/pubmed/33409108 http://dx.doi.org/10.7759/cureus.12395 |
Ejemplares similares
-
Hepatic Sarcoid-Like Reaction Mimicking Liver Metastases in a 36-Year-Old Female With Rheumatoid Arthritis
por: Khalil, Abdalla, et al.
Publicado: (2023) -
Sarcoid‐like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab
por: Takamori, Shinkichi, et al.
Publicado: (2021) -
Pembrolizumab-Induced Sarcoid-Like Reaction: FDG-PET Scan Interpretation in the Era of Immunotherapy
por: Malaty, Shiva, et al.
Publicado: (2020) -
Immunotherapy-Induced Sarcoid-Like Reaction: A Shrewd Imitator
por: Yasin, Hassaan, et al.
Publicado: (2021) -
Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
por: Honigman, Anthony D., et al.
Publicado: (2019)